Squarepoint Ops LLC Sesen Bio, Inc. Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.73 - $1.28 $63,561 - $111,449	-87,070 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.77 - $4.91 $67,043 - $427,513	87,070 New	87,070 $69,000
Q2 2021 Aug 16, 2021	SELL	$2.18 - $4.66 $91,904 - $196,456	-42,158 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.3 - $3.24 $54,805 - $136,591	42,158 New	42,158 $110,000
Q4 2020 Feb 16, 2021	SELL	$1.01 - $1.77 $197,346 - $345,845	-195,393 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$0.67 - $1.4 $122,980 - $256,974	183,553 Added 1550.28%	195,393 $274,000
Q2 2020 Aug 14, 2020	BUY	$0.52 - $0.87 $6,156 - $10,300	11,840 New	11,840 $9,000
Q4 2018 Feb 14, 2019	SELL	$0.96 - $2.04 $12,897 - $27,407	-13,435 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.54 - $2.38 $20,689 - $31,975	13,435 New	13,435 $29,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.